Aids-related Anorexia

• FDA approval · 2022-09-21
  FDA Approved: DRONABINOL — Supplemental Application (Wellhouse Pharma, LLC)

  FDA approved a supplemental application for dronabinol submitted by Wellhouse Pharma, LLC.

• FDA approval · 2016-07-01
  FDA Approved: DRONABINOL — Original Application (Wellhouse Pharma, LLC)

  FDA approved dronabinol under an original NDA submitted by Wellhouse Pharma, LLC.

• FDA approval · 2010-10-29
  FDA Approved: DRONABINOL — Supplemental Application (Rhodes Pharmaceuticals L.P.)

  The FDA approved a supplemental application for dronabinol from Rhodes Pharmaceuticals L.P., enabling a generic dronabinol product.

• FDA approval · 2008-06-27
  FDA Approved: DRONABINOL — Original Application (Rhodes Pharmaceuticals L.P.)

  FDA approves Rhodes Pharmaceuticals' original application for dronabinol (a generic), with indications for chemotherapy-induced nausea and v…

• FDA approval · 2006-06-21
  FDA Approved: DRONABINOL — Supplemental Application (Ascend Laboratories, LLC)

  FDA approved a supplemental application for dronabinol (Dronabinol) submitted by Ascend Laboratories, LLC. The product is used for chemother…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.